Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

schwabe pharma ag - ginkgonis estratto secco raffinatum e quantificatum (ginkgo biloba l., foglie) - compresse rivestite con film - ginkgonis extractum siccum raffinatum et quantificatum (ginkgo biloba l., folium) 120 mg corresp. flavonglycosida ginkgo 26.4-32.4 mg, ginkgolidae a, b et c 3.36-4.08 mg et bilobalidum 3.12-3.84 mg, der: 35-67:1, auszugsmittel acetonum 60% (m/m), lactosum monohydricum 68.25 mg, cellulosum microcristallinum, maydis amylum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium 1.65 mg, magnesii stearas, Überzug: hypromellosum, macrogolum 1500, e 172 (flavum), e 171, talcum, simeticonum, silica colloidalis anhydrica, macrogoli 5 aether stearylicus, e 200, pro compresso obducto. - caso di rallentamento della efficienza mentale; in caso di claudicatio intermittens; in caso di vertigini e tinnito - phytoarzneimittel

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 500 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 1 mg, ad granulatum, pro charta 930 mg corresp. natrium 1.62 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, carmellosum natricum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 2 mg, ad granulatum, pro charta 1.86 g corresp. natrium 3.24 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 1.5 g, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum k 24-27, e 171, aromatica (vanille-creme), aspartamum 3 mg, ad granulatum, pro charta 2.79 g corresp. natrium 4.86 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

dr. falk pharma ag - mesalazinum - granulat - mesalazinum 3000 mg, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, acidi ethacrylici et methylis methacrylatis polymerisatum, magnesii stearas, simeticonum, methylcellulosum, acidum sorbicum, carmellosum natricum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, triethylis citras, talcum, acidum citricum, povidonum, e 171, aromatica (vanille-creme), aspartamum 6 mg, ad granulatum, pro charta 5.58 g corresp. natrium 9.72 mg. - la colite ulcerosa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - dimethylis fumaras - capsule rigide gastroresistenti - dimethylis fumaras 120 mg, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, talcum, silica colloidalis anhydrica, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polysorbatum 80, natrii laurilsulfas, triethylis citras, talcum, simeticonum, kapselhülle: gelatina, e 171, e 172 (flavum), e 133, drucktinte: lacca, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 1.37 mg. - multiple sklerose - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

biogen switzerland ag - dimethylis fumaras - capsule rigide gastroresistenti - dimethylis fumaras 240 mg, carmellosum natricum conexum, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, natrii laurilsulfas, triethylis citras, polysorbatum 80, talcum, simeticonum, kapselhülle: gelatina, e 171, e 172 (flavum), e 133, drucktinte: lacca, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 1.69 mg. - multiple sklerose - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

future health pharma gmbh - risedronas - le compresse gastroresistenti di - natrii risedronas 35.0 mg corresp. risedronas 32.48 mg, cellulosum microcristallinum silicificatum, dinatrii edetas, carboxymethylamylum natricum a, acidum stearicum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, talcum, e 172 (flavum), simeticonum, polysorbatum 80, pro compresso obducto corresp. natrium 16.64 mg. - behandlung der osteoporose bei postmenopausalen frauen mit erhöhtem frakturrisiko - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

farma 1000 srl - magnesio idrossido/algeldrato/dimeticone - compresse/tavolet.masticabili - "plus compresse masticabili" 30 compresse - antiacidi, antimeteorici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bayer (schweiz) ag - calcii carbonas, magnesii subcarbonas ponderosus, simeticonum - pastiglie - calcio carbonas 680 mg, magnesio subcarbonas ponderosus 80 mg, simethiconum 25 mg, sono, excipiens pro compresso. - antacidum - synthetika